$128.16
0.950.74%
Pre-Market: Sep 20, 7:25 PM EDT
15 minutes delayed
Sarepta Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sarepta Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $0.44 | $0.02 | 2100.0 % |
Mar 2024 | 2024-05-01 | $0.73 | $-0.07 | 1142.9 % |
Dec 2023 | 2024-02-28 | $0.82 | $0.01 | 8100.0 % |
Sep 2023 | 2023-11-01 | $0.37 | $-1.32 | 128.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $362.93M | $396.26M | -8.41 % |
Mar 2024 | 2024-05-01 | $413.46M | $373.28M | 10.8 % |
Dec 2023 | 2024-02-28 | $396.78M | $385.81M | 2.84 % |
Sep 2023 | 2023-11-01 | $331.82M | $288.50M | 15.0 % |
Sarepta Therapeutics (SRPT) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $0.44, which beat the estimate of $0.02.
The Actual Revenue was $362.9M, which missed the estimate of $396.3M.
Browse earnings estimates, EPS, and revenue on all stocks.